Market Launch of First Factor Xa Reversal Agent in European Countries
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
ESO Committee Corner: Trials Alliance (ESOTA)
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
ESO Members Participate in IRENE COST Action Meeting in Moldova
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Stroke Action Plan Europe: first steps towards implementation
[et_pb_section fb_built="1" _builder_version="3.22.7"][et_pb_row…
FESO Interview with Marco Duering
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Syphilitic Vasculitis: a mysterious and dangerous cause of stroke in the young
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Call for Bids ESO Summer School 2022
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
ESO Department to Department Visit Report – Silvia Chirobocea
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…
Bundle of care to improve outcomes after intracerebral haemorrhage: as easy as ABC?
[et_pb_section fb_built="1" _builder_version="3.22.3"][et_pb_row…